← Back
Data updated: Mar 10, 2026
CORMEDIX
Infectious Disease
CORMEDIX is a pharmaceutical company focused on Infectious Disease. Key products include DEFENCATH.
2023
Since
1
Drugs
-
Trials
1
Approved (2yr)
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 100%
1 drugs Phase 3: 2 Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2023-11-15
- Latest
- 2024-12-19
- Applications
- 1